Study: Early Intervention Reduces Depression in Patients With AMD

Research suggests early intervention with low-vision aids can reduce the severity of depression related to vision loss in people with age-related macular degeneration, according to a Medscape News report.

Advertisement

The small pilot study was presented at the World Ophthalmology Congress 2012 in Abu Dhabi, United Arab Emirates. Twenty-two patients aged 65-85 were split into two groups: those who received immediate intervention and those who waited three months before starting rehabilitation.

At baseline and after three months, patients were tested using the Geriatric Depression Scale and the Center for Epidemiological Studies Depression Scale. Both scores for the early intervention group decreased. The average CES-D score decreased from 8.8 at baseline to 6.1 at three months, and the average GDS scored decreased from 4.4 at baseline to 4.0 at three months. Both scores increased in the control group. The average CES-D score increased from 8.0 at baseline to 10.9 at three months, while the average GDS score increased from 3.4 at baseline to 4.2 at three months.

Related Articles on Ophthalmology:

Study: Playing Video Games Could Improve Cataracts in Young Patients
Elisabeth Severance Prentiss Foundation Donates $5M to Cleveland’s University Hospital Eye Institute
10 Recent Moves, Appointments for Ophthalmologists

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

  • From payer obstacles to operational pressures, five ASC leaders discuss the biggest frictions they’re facing. Note: Responses were lightly edited.…

Advertisement

Comments are closed.